Key Highlights

● NewGenIvf Group (NIVF) closed at $0.34 on Monday, down 38.44% from $0.56, one of the larger declines among Nasdaq stocks.

● The Bangkok-based company runs fertility clinics offering in vitro fertilization, or IVF, across several Asian markets, per profile data.

● NewGenIvf reports current events on Form 6-K, and no filing or release dated Monday was found to explain the drop.

● The Russell 2000 fell 19.64 points and Nasdaq stocks set 461 new 52-week lows against 50 new highs on Monday.

NewGenIvf Group (NASDAQ:NIVF) plunged on Monday, September 28, closing at $0.34, down 38.44% from $0.56 on Friday. It was one of the larger percentage declines among Nasdaq-listed stocks that day. The company provides fertility services, including in vitro fertilization, known as IVF.

No fresh company disclosure dated Monday was found, and this article does not speculate on what drove the trading.

A Fertility Business in Asia

According to company profile data, NewGenIvf is based in Bangkok and operates fertility clinics in Thailand, Cambodia, Hong Kong and Kyrgyzstan. Its services include IVF, embryo culture and related diagnostics, with supplementary support such as counselling and nutritional guidance. Nothing in that description accounts for Monday's move.

The company was founded in 2011, according to profile data, and its co-founder Wing Fung Siu serves as chairman and chief executive. Fertility care is a growing field as more people start families later in life, though that context says nothing about why the shares fell on Monday.

Where Disclosures Appear

As a company based outside the United States, NewGenIvf reports current events on Form 6-K and annual results on Form 20-F, and those filings, along with its press releases, are the place to check for dated information. Exchange notices would also be public. Such disclosures can cover clinic operations, financing arrangements and share issuance, each with dates and specifics that price data lacks.

Trading Below a Dollar

With the shares at $0.34, well below the $1 level Nasdaq generally requires for continued listing, investors in low-priced stocks tend to watch company filings closely. A company below the threshold usually receives a compliance period, sometimes resolved through a reverse stock split. That is a description of general rules, not of any action involving NewGenIvf.

The Wider Session

The Nasdaq Composite closed down 248.34 points at 26,820.38, while the S&P 500 lost 59.72 points to 7,683.69. Breadth beneath the surface was poor. The Russell 2000 slipped 19.64 points, while the Nasdaq logged 461 new 52-week lows and just 50 new highs.

Rates did much of the damage. The 10-year Treasury Yield touched its highest level since 2007, and the 30-year hit its highest since 2004, which weighed on richly valued shares.

What to Watch for NewGenIvf

Investors will look for any Form 6-K or press release from NewGenIvf that could shed light on the price action, along with any update on its clinics and its Nasdaq listing status.

On the data front, the week runs from JOLTS and consumer confidence on Tuesday through PCE Inflation on Wednesday and ISM Manufacturing on Thursday to the September jobs report on Friday. The Fed's September hike keeps interest rates in focus for low-priced shares.